Mark Bodmer, CSO, President of R&D: Evelo Biosciences EVLO Sell · Filed 23/08/09

Trade details

Type: Insider sale
Amount: $29,747.28
Shares · price: 3,128 sh · $9.51 a share
Held after: 16,624 sh
Stock: Evelo Biosciences EVLO
Person: Mark BodmerCSO, President of R&D
Trade date: 23/08/08
Filed: 23/08/09
Days to filing: 1 days

Sold 15.8% of holdings

Share of holding sold: 15.8%

Evelo Biosciences trades, last 26 weeks

What else happened in Evelo Biosciences around then

Filed or reported within 30 days of the trade day · 23/07/09~23/09/07

Mark Bodmer's recent trades

Mark BodmerCSO, President of R&D
Sell10b5-1 planEvelo Biosciences
Sell10b5-1 plan
Evelo Biosciences
EVLO
$1,044
3,163 sh
$1,044
Filed 23/11/08
Traded 23/11/08
Mark BodmerCSO, President of R&D
Sell10b5-1 planEvelo Biosciences
Sell10b5-1 plan
Evelo Biosciences
EVLO
$2,262
6,854 sh
$2,262
Filed 23/11/03
Traded 23/11/02
Mark BodmerCSO, President of R&D
Sell10b5-1 planEvelo Biosciences
Sell10b5-1 plan
Evelo Biosciences
EVLO
$3,160
22,571 sh
$3,160
Filed 23/06/12
Traded 23/05/23
Mark BodmerCSO, President of R&D
Sell10b5-1 planEvelo Biosciences
Sell10b5-1 plan
Evelo Biosciences
EVLO
$8,842
68,014 sh
$8,842
Filed 23/05/10
Traded 23/05/08